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A super-enhancer (SE) is a cluster of enhancers with a relatively high density of particular
chromatin features. SEs typically regulate key genes that can determine cell identity and
differentiation. Identifying SEs and their effects may be critical in predicting key regulatory
genes, such as master transcription factor genes or oncogenes. Signal inducible SEs
are dense stretches of signal terminal transcription factor (TF) binding regions, and may
modulate the interaction between environmental factors (e.g., Vitamin D) and genetic
factors (i.e., risk variants) in complex diseases such as multiple sclerosis (MS). As
a complex autoimmune disease, the etiology and progression of MS, including the
interaction between Vitamin D and MS risk variants, is still unclear and can be explored
from the aspect of signal SEs. Vitamin D [with its active form: 1,25(OH)2D3], is an
environmental risk factor for MS. It binds the Vitamin D receptor (VDR) and regulates gene
expression. This study explores the association between VDR super-enhancers (VSEs)
and MS risk variants. Firstly, we reanalyse public ChIP-seq and RNA-seq data to classify
VSEs into three categories according to their combinations of persistent and secondary
VDR binding. Secondly, we indicate the genes with VSE regions that are near MS risk
variants. Furthermore, we find that MS risk variants are enriched in VSE regions, and we
indicate some genes with a VSE overlapping MS risk variant for further exploration. We
also find two clusters of genes from the set of genes showing correlation of expression
patterns with the MS risk gene ZMIZ1 that appear to be regulated by VSEs in THP-1 cells.
It is the first time that VSEs have been analyzed, and we directly connect the genetic risk
factors for MS risk with Vitamin D based on VSEs.
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INTRODUCTION
The transcription of genes depends on the interaction of their
promoter regions with polymerases that synthesize RNA from
genomic DNA in combination with an array of regulatory factors
(1, 2). Additionally, transcription is aided by cis-acting regulatory
elements that can be located relatively distant to the promoter
region and can bind activator proteins. These enhancer elements
are able to increase the level of gene transcription.
Super-enhancers (SEs) are dense clusters of enhancers. They
differ from typical enhancers (TEs) in the density of enhancer
elements. Enhancers, including both TEs and SEs, can be
annotated by histone status, i.e., H3K27ac and H3K4me1.
In addition, high chromatin accessibility [e.g., as determined
using FAIRE-seq or DNaseI hypersensitive sites (DHS)], master
transcription factor binding (e.g., PU.1 for monocytes, RORγt for
Th17 cells), and pervasive factors in the transcription machinery
(e.g., p300, MED1, BRD4, and RNA polymerase II) are all highly
correlated with SE regions and can be used to identify SE regions.
Although defined arbitrarily according to enhancer signal
density, SEs have proved extremely valuable in predicting key
regulatory regions or genes for cell identity or cell differentiation
(3). For example, inappropriate acquisition of SE in an oncogene,
such as c-MYC, will increase its expression and lead to
oncogenesis (4, 5). SE regions promote the expression of
autoimmune disease-associated genes. For example, the drug
JQ1 [BET (bromodomain and extra-terminal domain) inhibitor]
inhibits the expression of inflammatory arthritis risk geneCXCR4
by affecting its SE region (6), and tofacitinib [JAK (Janus
kinase) inhibitor] disproportionately inhibits the expression of
rheumatoid arthritis risk genes with SE regions compared with
those risk genes without SE regions (7).
Previous research has focused on classic SEs identified by
chromatin accessibility, master transcription factors or pervasive
factors in the transcription machinery, but recently, a new
concept of signal-inducible SEs has been proposed (8). It was
found that estrogen could induce the generation of new signal
SE regions, which were bound by the terminal transcription
factor (TF) ERα of the estrogen signaling pathway. The advantage
Abbreviations: BMDM, bone marrow-derived macrophages; ChIA-PET,
chromatin interaction analysis by paired-end tag sequencing; ChIP-seq,
chromatin immunoprecipitation sequencing; CTCF, CCCTC-binding factor;
dex, dexamethasone; DHS, DNase hypersensitivity sites; D3, 1,25(OH)2D3;
ECC-1, endometrial cancer cell line; eQTL, expression quantitative trait loci;
GR, glucocorticoid receptor; GRSE, super-enhancer formed by GR binding
regions; ERα, estrogen receptor α; ER SE, super-enhancer formed by ERα binding
regions; E2, estradiol; FAIRE, formaldehyde-assisted isolation of regulatory
elements; FSE, super-enhancer formed by FAIRE regions; GEO, gene expression
omnibus; GM10855/GM10861, human lymphoblastoid cells; GWAS, genome
wide association studies; LD, linkage disequilibrium; LS180, human colorectal
cancer cells; LX2, human hepatic stellate cells; MED1, mediator complex subunit
1; MCF-7, human breast cancer cells; mESC, murine embryonic stem cells;
MS, multiple sclerosis; NGS, next generation sequencing; PSE, super-enhancer
formed by PU.1 binding regions; RS4;11, human acute leukemia cells (B cell
and monocyte like); SE, super-enhancer; SNP, single nucleotide polymorphism;
TAD, topologically associating domain; TE, typical enhancer; TF, transcription
factor; THP-1, human monocyte-like cells; VDR, Vitamin D receptor; VSE,
super-enhancer formed by VDR binding regions; VTE, typical enhancer formed
by VDR binding.
of signal SEs for research is that they can provide important
information on the signal terminal TF cistrome before and after
signal stimulation.
Multiple sclerosis (MS) is a complex autoimmune disease with
multiple risk factors including genetic variants and Vitamin D
deficiency (9, 10). Until now, the functional variants of many
genome-wide association study (GWAS) loci have not been
identified. In addition, the mechanism underlying the interaction
between genetic factors and Vitamin D in MS etiology and
progression is still unclear. Some MS risk single nucleotide
polymorphisms (SNPs) have been found located in Vitamin D
Receptor (VDR) binding sites in lymphoblastoid cell lines (LCLs)
(11) and conversely, VDR binding sites are also enriched in MS
risk regions identified by GWAS (MS risk SNP ± 100 kb) (12).
Furthermore, MS risk SNPs are enriched in classic SE regions
of CD4+ T cells and monocytes (3, 7). The risk alleles could
potentially modulate the regulatory effects of these SEs on key
genes in specific cell types.
We hypothesize that VDR super-enhancers (VSEs) may be
signal inducible SEs relevant to MS development, and that
GWAS-identified MS risk loci may influence the function of
such VSEs. To assess this, we re-analyzed next-generation
sequencing (NGS) data from cell stimulation experiments
employing hormones and their nuclear receptors. In particular,
we were interested in the 1,25(OH)2D3 (the active form of
Vitamin D) and VDR couple, and its association with MS. Firstly,
we analyzed the overlap between VSEs and classic SEs on their
genomic regions and closest genes. We classified all VSEs into
three patterns (VSE1: only persistent VDR binding; VSE2: both
persistent and secondary VDR binding; VSE3: only secondary
VDR binding) and analyzed their characteristics. Furthermore,
we analyzed the enrichment of MS risk SNPs in VSE regions,
and confirmed that VSEs were significantly enriched for MS
risk SNPs.
ZMIZ1 and EOMES have been identified as MS risk genes by
cohort studies, and are differentially expressed in whole blood
between MS patients and healthy controls (13–15). ZMIZ1 is
highly expressed in monocytes and EOMES is predominantly
expressed in NK cells. ZMIZ1 is known to regulate the activity
of various transcription factors. ZMIZ1 and a set of genes
with a correlated expression pattern are under-expressed in
blood of MS patients (15). We identified two gene clusters
in the ZMIZ1-correlated gene set, one with high response to
1,25(OH)2D3 and the other with high expression levels in THP-
1 cells, that are potentially affected by VSE2 regions and VSE3
regions, respectively.
Our research shows an association between VDR super-
enhancer regions and MS risk for the first time.
MATERIALS AND METHODS
Next Generation Sequencing
Data Selection
We downloaded unstimulated and 1,25(OH)2D3-
stimulated VDR ChIP-seq, PU.1 ChIP-seq, FAIRE-seq, and
RNA-seq data in THP-1 cells, and other hormone/nuclear
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receptor (i.e., estrogen/ERα and dexamethasone/GR) NGS
data (SRA format), from the NCBI Gene Expression Omnibus
(GEO) database (Table 1 and Table S1). Then FASTQ files were
converted from the SRA files with command “fastq-dump.”
ChIP-seq Pipeline
Bowtie2 was used to align FASTQ files to the hg19 reference
genome with bowtie2 indexes (“bowtie2 -x -U -S”) (19). We
defined peaks with MACS2 (20). For ChIP-seq data from
transcription factors VDR and PU.1, we used the command
“macs2 callpeak –bw 150 –keep-dup 1 -q 0.01 –B.” For FAIRE-
seq, we used a nomodel command “macs2 callpeak –nomodel
–shift−75 –extsize 150 –keep-dup 1 -q 0.01 –B.” Potential artifact
signals, based on publicly available blacklists of genomic regions
known to have anomalous, unstructured, high signal/read counts
in next gen sequencing experiments (21), were removed from the
peak sets using “BEDTools intersect” (22).
Identification and Classification of
Super-Enhancers
We distinguished SEs from TEs using ROSE with command
setting “-t 2000 -s 12500” (4, 23). Firstly, promoter regions [i.e.,
2 kb upstream and downstream of the transcription start site
(TSS)] with ChIP-seq or FAIRE-seq annotations were excluded.
Then enhancer regions identified by the chosen enhancer
annotation were stitched together within defined regions of
length 12.5 kb to generate signal densities and ranked in order of
enhancer density. On a plot of signal density vs. density rank the
tangent point is identified by a tangent line with a slope of 1 and
divides the enhancers into two types: SEs (with higher density,
to the left of the tangent point) and typical enhancers (TEs with
lower density, to the right of the tangent point) (3, 4, 23).
To count the signal density for density correlation analysis,
reads were extended by 200 bp and the density of reads
per base pair was calculated using bamToGFF (https://github.
com/BradnerLab/pipeline), which ROSE integrates internally for
identifying SEs (3, 23). These densities were normalized in units
of reads per million mapped reads per base pair (rpm/bp)
with background subtraction for density correlation analysis
between different transcription factors. Integrative Genomics
Viewer (IGV) was used to visualize genomic signal density (24).
To classify VSE regions, we firstly defined primary (existing
only before signal stimulation), persistent (existing both before
and after signal stimulation) and secondary (existing only after
signal stimulation) VDR binding sites by comparing VDR
binding sites before and after 1,25(OH)2D3 stimulation. We
then selected VSEs after signal stimulation that overlap with
persistent VDR binding only (classified as VSE1), secondary VDR
binding only (classified as VSE3), or both (classified as VSE2).
We also selected VSEs before signal stimulation that overlap with
persistent VDR binding only (classified as VSE4), primary VDR
binding only (classified as VSE6), or both (classified as VSE5).
“BEDTools intersect” (22) was used to classify VSE regions by
intersecting VSEs with the different types of VDR binding sites.
Assigning a Gene to Its Closest
Super-Enhancer
We assigned all genes with GENCODE hg19 gene/lncRNA
annotations to their closest SEs within a 50 kb window using
“BEDTools closest” (22). This window size can identify most
true enhancer/promoter interactions as reported in previous
studies (3, 23, 25, 26). We used the Venny 2.1 online tool
(http://bioinfogp.cnb.csic.es/tools/venny/) (27) to generate Venn
diagrams of the interactions between gene sets.
MS Risk SNPs
MS risk SNPs were downloaded and merged from both NHGRI
GWAS Catalog data (https://www.ebi.ac.uk/gwas/search?query=
MULTIPLE%20SCLEROSIS) and the most recent International
MS Genetics Consortium (IMSGC) results (BioRxiv: https://
doi.org/10.1101/143933). SNPs in linkage disequilibrium with
the list of MS risk tag SNPs were determined from both
HapMap3 and the 1000 Genomes Project using r2 > 0.8,
distance limit= 500 kb and population CEU (Center d’Etude du
Polymorphisme Humain–Utah) using the SNP Annotation and
Proxy Search (SNAP) tool (https://www.broadinstitute.org/snap/
snap) (28).
Enrichment Analysis in Super-Enhancer
Regions
Enrichment levels of TF binding sites or SNPs in SE regions
were analyzed via permutation test using the “region” R package,
with z-score as a measure of the strength of the association
that is independent of the number of permutations (29). As
z-score is defined as the distance between the expected value
and the observed one, measured in standard deviations, we use
z-score 1.96 as a significance test for two sided p < 0.05. Enquiry
regions (e.g., SNP regions), were normalized by dividing them
by the total size of the regions of interest (VSE: 24,014,217
bp, VSE1: 82,635 bp, VSE2: 1,280,936 bp, VSE3: 1,040,646 bp,
VDR typical enhancer (VTE): 5,787,494 bp, PU.1 identified SE
(PSE): 5,496,182 bp, FAIRE-seq identified SE (FSE): 1,182,725
bp) and reporting them in every 10Mb of the genome as
described in (7). The permutation test for the enrichment p-value
was performed by generating 1,000 permutations of regions
of interest (VSE, VTE, PSE, FSE) in the genome (excluding
blacklisted regions and the region of interest itself in each
permutation) and considering the total size-normalized number
(number per 10Mb) of overlaps between the enquiry region and
the region of interest.
For the SNPs enriched in SE regions, we used RegulomeDB
to identify DNA features and regulatory elements such as
eQTLs, chromatin signatures and transcription factor binding
sites overlapping with these SNPs (30). RegulomeDB scores these
SNPs according to the strength of their risk evidence. We report
only the SNP with the top score in each SE region.
Analysis of Super-Enhancer Region
Characteristics
We performed gene ontology analysis on super-enhancer
regions using the Genomic Regions Enrichment of Annotations
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TABLE 1 | Control and 1,25(OH)2D3 (D3)-stimulated ChIP-seq, FAIRE-seq, and RNA-seq data in THP-1 cells (VDR_1).
Transcription factor Cell type Signal Treatment Organism Vehicle Hormone References
VDR THP-1 D3 100 nM 24h human GSM2371448 GSM2371449 (16)
SRR4828896 SRR4828897
PU.1 THP-1 D3 100 nM 24h human GSM2359982 GSM2359983 (17)
SRR4450164 SRR4450165
Faire-seq THP-1 D3 100 nM 24h human GSM1697277(0h) GSM1697279 (18)
SRR2042800 SRR2042802
RNA-seq THP-1 D3 100 nM 24h human GSM1697100,06,12 GSM1697101,07,13 (18)
SRR2042584,90,96 SRR2042585,91,67
Input GSM1714041 (18)
SRR2067928
Tool (GREAT version 3.0.0) with the whole genome as
background and default parameters (31). Pearson’s product
moment correlation coefficient was used to test for association
between paired TF binding densities with value log2(rpm/bp)
at the same regions. The “ggpubr” R package (https://CRAN.
R-project.org/package=ggpubr) was used to produce correlation
plots. The p-value for correlation was corrected by Bonferroni
correction. “BEDTools nuc” (22) was used to count GC content
in genomic regions.
RNA-seq Pipeline to Determine Genes
Regulated by 1,25(OH)2D3
Hisat2 was used to align sequences (three replicates of RNA-
seq data) to the hg19 reference genome with Hisat2 indexes
(32). The resulting BAM files were sorted by read name, then
Htseq was used to count reads on exons in GENCODE hg19
gene annotations with the command “htseq-count -s no -m
intersection-nonempty -i gene_name” (33). We only retained
genes expressed at a counts-per-million [CPM: calculated using
the function cpm from the edgeR library (34) in R]>0.5 in at least
two samples. The function “voom” from the limma R package
was used to find differentially expressed genes, and “treat” was
used to correct the voom results relative to a false discovery
rate of 5%. Genes with p < 0.05 and log2(fold change) ≥1 were
considered to be significantly regulated.
The “dunn.test” R package (https://CRAN.R-project.org/
package=dunn.test) was used for multiple pairwise comparisons
with Bonferroni correction after a Kruskal–Wallis test on
the expression level or the regulatory effect between different
VDR binding patterns. Violin plots, boxplots, SE curve and
transcriptome plots were generated using the “ggplot2” R
package (35).
ZMIZ1 Gene Set
To generate the gene set that is positively associated with the
expression ofMS risk gene ZMIZ1 in whole blood, wemerged the
top 200 genes [data from (14, 15)] that are positively correlated
with ZMIZ1 expression from each of three cohorts: ANZgene
(microarray) cohort (36), Sydney RNASeq cohort (37), clinically
isolated syndrome (CIS) cohort (38).
Gene Set Enrichment Analysis
Analyses focused only on genes under the significant regulation
of 1,25(OH)2D3 (p < 0.05 and log2(fold change) ≥1) or with a
high expression level (average log2(expression) >5) ignore the
genes that have a relatively small change or a low expression level,
which can nevertheless function in a coordinated way in a set
of related genes. Gene set enrichment analysis (GSEA) (39, 40)
addresses this limitation and was used to find the enrichment
distribution of a specific gene set (e.g., VSE gene sets) in a certain
pre-defined and pre-ranked gene set (e.g., ZMIZ1 gene set ranked
by log2(fold change) or by average log2(expression) from high to
low), which can indicate a cluster of enriched important genes
with a relative high change even though their log2(fold change)
<1, or with a high expression level even though their average
log2(expression) ≤5.
Gene Ontology Analysis on Gene Clusters
Gene ontology (GO) biological process (BP) terms and Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways are used
to annotate the function of ZMIZ1-associated VSE gene clusters
via “clusterProfiler” R package (41). For GO biological process
(BP) analysis, we report the top six significant biological process
terms with p < 0.05 and q < 0.01.
RESULTS
The Difference Between Signal SEs and
Classic SEs
As the VDR is the only receptor and terminal TF for the
signal molecule 1,25(OH)2D3 (the active form of vitamin D), the
cistrome, especially the SE region, of the active VDR reflects the
genomic effect of 1,25(OH)2D3. For this study, we used NGS data
from THP-1 cells (human monocytic cell line derived from an
acute monocytic leukemia patient) before and after 1,25(OH)2D3
stimulation (Table 1).
To explore the difference between signal SEs (e.g., those
identified by VDR binding) and classic SEs (e.g., those identified
by master TF binding, H3K27ac, or accessible chromatin
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FIGURE 1 | VDR, PU.1, FAIRE identify different SE regions with different genes nearby and gene function enrichment, respectively. (A) The (signal density)/(density
rank) curve for SE calling from VDR, PU.1 and FARIE. (B) The number of enhancers (E) and super-enhancers (SE) before and after 1,25(OH)2D3 stimulation. (C) The
Venn overlap figure for the gene list near VSE, PSE and FSE in 50 kb regions. VSE, VDR SE; PSE, PU.1 SE; FSE, FAIRE SE. (D) The enrichment analysis of GO
biological process gene set for VSE, PSE and FSE; orange bar: the shared process between VSE and PSE (GEO data shown in Table 1).
regions), we called SE regions using data from VDR ChIP-
seq, PU.1 ChIP-seq (master TF binding regions), and FAIRE-
seq (chromatin open regions) (Supplementary File 1). We found
that both PU.1 and FAIRE-seq provided a much clearer
distinction between SEs and TEs on the density curve than VDR
did (Figure 1A). VDR binding regions achieved higher signal
densities and were identified as SE regions at lower ranks (higher
rank numbers) (Figure 1A) compared to PU.1-identified SEs
(PSEs) and FAIRE-seq-identified SEs (FSEs). As well as higher
signal density, the number of VDR enhancers also increased
strongly after 1,25(OH)2D3 stimulation (Figure 1B). Although
the numbers of enhancers identified by PU.1 ChIP-seq and
FAIRE-seq also increased greatly after stimulation, the numbers
of their SEs increased much less than the number of VSEs
(Figure 1B). These results reflect the higher sensitivity of signal
SE formation in response to signal stimulation compared with
that of classic SE formation.
The VSE gene set (the closest genes within 50 kb around
VSEs) shares only minor overlap with the PSE and FSE gene sets
(Figure 1C). Gene ontology (GO) analysis on super-enhancer
regions consistently shows that VSE, PSE, and FSE have different
functional gene enrichment, except that the “positive regulation
of immune system process” gene set is enriched in both VSE
(Supplementary File 1 and Figure 1D) and PSE (Figure 1D).
From the GO analysis (Figure 1D), only PSE genes are all
enriched in immune associated processes. FSE genes are more
often related to other functions, such as “cell mobility” and “cell
migration,” and VSE genes are more clearly associated with “cell
activation” and “bone mineralization” (Figure 1D).
Classification of VDR Super-Enhancers
As classic SEs appear to play a minor role in genomic responses
to signal given their small increase in numbers after signal
stimulation, VSEs should potentially play a greater role in
1,25(OH)2D3 stimulated THP-1 cells. By analyzing the data from
THP-1 cells, we found that there were numerous signal VSE
regions with persistent VDR binding only (classified as VSE1,
n = 126), or with secondary VDR binding only (classified as
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FIGURE 2 | The classification of VSEs and their association with the region and density of PU.1 and FAIRE. (A) Classification hypothesis: six types of VSE pattern.
VSE4–6 exist without 1,25(OH)2D3 treatment. VSE1–3 are gained after 1,25(OH)2D3 treatment. VTE, VDR typical enhancer; VSE, VDR SE; PSE, PU.1 SE; FSE, FAIRE
SE; yellow bar, high read density in narrow region identified as SE; read density of bar, yellow> green; blue line, genomic region; The colon of VSE1–6 followed by the
number of locations observed that match the pattern in THP-1 cells. (B) The representative genomic binding density of VDR, FAIRE, and PU.1 in VSE1–3. (C) The
signal density correlation between PU.1, VDR and FAIRE in VSE1–3 regions.
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TABLE 2 | The number of signal SE 1–3 for different signals and in different cell types.
Cell type THP-1 THP-1 MCF-7 MCF-7 RS4;11 BMDM*
Corresponding data (Table 1
and Table S1)
VDR_1 VDR_2 ER_1 ER_2 GR_1 GR_2
Signal stimulation D3 D3 E2 E2 dex dex; LPS
Transcription factor VDR VDR ERα ERα GR GR
Treatment 100 nM 24h 10 nM 40min 100 nM 1h 100 nM 45min 10 nM 1h 100 nM 45min; 10 ng/ml 45 min
After stimulation SE1 110 41 17 43 0 1
SE2 140 6 151 639 0 4
SE3 126 19 21 0 623 67
D3, 1,25(OH)2D3; E2, estradiol; dex, dexamethasone; LPS, lipopolysaccharides.
*Using mm10 reference genome.
Bold values: the number of the major SE type.
VSE3, n= 110), and an even greater number with both persistent
and secondary binding (classified as VSE2, n = 140) (Figure 2A
and Supplementary File 1).
In undertaking these analyses, we assumed that all six
potential patterns of VSE were possible (i.e., primary binding,
secondary binding or both, before and after 1,25(OH)2D3
stimulation). Three patterns (VSE4–6) lose their VSE status
after treatment and three patterns (VSE1–3) gain VSE status
after treatment (Figure 2A). However, we found no evidence
for VSE5 or VSE6 existing, and none of the 31 VSE4 regions
degenerated into typical enhancers after stimulation. Of the VSE4
regions, 14 were persistent as VSE1 after stimulation, and 17
VSE4 regions initiated secondary VDR binding around them
reclassifying as VSE2 after stimulation (Figure 2A). We therefore
classify the signal SEs after stimulation into three types: VSE1,
VSE2, and VSE3 (Figures 2A,B). Among them, the densities
of PU.1/FAIRE-seq and VDR are correlated with each other in
VSE2 and VSE3 regions, while the densities of VDR in VSE1 are
too high to be correlated with either PU.1 binding density or
FAIRE-seq density (Figure 2C).
A previous study found that persistent VDR binding sites
have more canonical motif enrichment. Further, different
combinations of persistent and transient VDR binding sites
in topologically associating domains (TADs) regulate different
biological processes (16). Another previous study found that
the persistent signal enhancer (ERα binding) initiates the whole
signal SE (ERα SE) region by promoting the activation of
secondary enhancers (ERα binding) around it after estrogen
stimulation, which is the same pattern seen for VSE2 in our study
(Figure 2A) (8). To explore the reason the previous study on
ERα SEs did not find ERα SE1 and SE3 patterns, but only SE2
(i.e., persistent ERα binding initiates a long ERα SE region), we
analyzed ChIP-seq data for two other nuclear receptors (ERα and
glucocorticoid receptor) in other cell types. We found that the
different signals have different distributions of their signal SE1–
3s (Table 2, data set shown in Table S1) (42–46), confirming the
signal specificity for the proportions of signal SE1–3 patterns. The
major pattern of ERα SEs is SE2 with only a few SE1 and SE3,
which explains why previous reports only provides one model
for signal SEs (i.e., only the SE2 pattern) (8). For dexamethasone
stimulation, the major pattern of glucocorticoid receptor (GR)
SEs is GR SE3 with a few SE1 and SE2 in either human B cell type
(RS4;11) or mouse macrophage (BMDM).
The Regulatory Effects of VSEs on the
Expression of MS Associated Genes
To explore the regulatory effect of VSEs on MS gene expression,
we investigated all 202 genes that are significantly regulated
by 1,25(OH)2D3 stimulation [with p < 0.05 and log2(fold
change) ≥1] (data set shown in Table 1). The VSE regions
account for 73 of the 202 differentially expressed genes and
there is little overlap between the gene sets regulated by
the three classes of VSEs (Figure 3A). All 73 VSE-regulated
genes are shown in Figure S1, with representative genes shown
in Figure 3B.
As the high level of average expression [i.e., average
log2(expression) >5] indicates a basic high chromatin
accessibility, we tested the average expression level of VSE1–3
gene sets. We found that genes with VDR binding in the
promoter region have higher average expression levels than all
other VDR binding patterns except VSE3 (Figure 3C). Both the
gene sets of VSE3 and VDR promoter binding, but not VSE1
and VSE2, have a higher average expression level than the VDR
TE gene set (Figure 3C). Consistently, we found that among
VSE1–3, only VSE3 has a significantly higher GC content than
VDR TE, and it has a modestly, although not significantly, higher
GC content than VSE1 and VSE2 (Figure 3D), suggesting a more
active regulatory conformation and more frequent TF binding
(BioRxiv: http://dx.doi.org/10.1101/105262).
However, high expression does not mean a stronger
regulatory effect. We found that all VSE1–3 regions have a
significantly stronger regulatory effect on gene expression than
VDR promoter binding (Figure 3E). VDR promoter binding
in turn has a significantly stronger regulatory effect than
VDR TE (Figure 3E).
We identified MS risk regions detected by GWAS (MS risk
SNP ± 500 kb) that overlap with VSEs, and further evaluated
Frontiers in Immunology | www.frontiersin.org 7 March 2019 | Volume 10 | Article 488
Lu et al. Vitamin D Induces Super-Enhancers
FIGURE 3 | The regulatory effects of VSE1–3 on gene expression. (A) The overlap between VSE1–3 close genes. (B) The visualization of signal density in
representative VSE1–3 regions. (C) Average expression level of genes close to different regulatory patterns. (D) The GC content of VSE and VTE. (E) Regulatory effect
of different regulatory patterns on gene expressions. VSE, VDR SE; VTE, VDR typical enhancer; VP, VDR promoter binding. To analyse statistical significance, we used
a Kruskal–Wallis test followed by Bonferroni correction *p < 0.05.
the expression levels of genes in these regions in response to
1,25(OH)2D3 exposure in THP-1 cells (Table 3 and Figure S2).
Among them, genes DENND6B, USP2, ASAP2, SEMA6B, and
LRG1 not only have VSE regions and are near MS risk
SNPs, but also are significantly regulated by 1,25(OH)2D3 and
highly expressed in THP-1 monocytes. Interestingly, few highly
expressed genes with VSE3 patterns are significantly regulated
by 1,25(OH)2D3.
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TABLE 3 | The genes with VSEs that are associated with MS risk SNPs.
Genes with VSE that within
500kb of MS risk SNPs
Genes under significant regulation
(Log2FC > 1 and p < 0.05)
Genes with high expression level
(Log2AverExp > 5)
Both of above
with VSE1 DENND6B PDCD1LG2 USP2 ASAP2
USP2-AS1 AC080112.2
DENND6B USP2 ASAP2 AIG1 VPS37B PLXNB2
RNF26 YPEL3 ALDOA PPP4C RARA PPP6R2
ZC3HAV1 TOP2A
DENND6B USP2
ASAP2
with VSE2 IGLV7-46 SEMA6B NR1I2 LRG1 SEMA6B LRG1 MYO9B CYTH4 BCL9L ELL MUC1
LCP2 CLCN7 TOP1 TELO2 ZMIZ1 COLGALT1
SLC27A1 RAC2 NR2F6 GSE1 PGLS SLC50A1
FKBP8 IRF8 UBASH3B DPM3 GBA GSK3B
UBAC2 THBS3
SEMA6B LRG1
with VSE3 LINC00917 AC023590.1 LRRC25 ELL CUEDC1 IRF5 SLC45A4 RAB3D MRPS7 PLEC
RAB44 PLPPR2 CLSTN1 PARP10 MRPS23
SLC25A19 GGA3 GRINA GRB2 TNPO3 PGPEP1
SSBP4 MIF4GD IKZF1
null
MS Risk SNPs Are Enriched in VSE
Regions of THP-1 Cells After 1,25(OH)2D3
Stimulation
The known MS risk SNPs have previously been found to
be enriched in classic SE regions (identified by H3K27ac) of
monocytes (3, 7). Therefore, we aimed to determine if MS risk
SNPs are enriched in VSEs, as causal SNPs in these regions may
have the potential to modulate the Vitamin D responsiveness of
MS risk genes.
Firstly, we analyzed the enrichment of known MS risk SNPs
in both classic SE (identified by PU.1 peaks or FAIRE-seq peaks)
and signal SE (VSE) regions after stimulation with 1,25(OH)2D3.
We found that VSE regions are also enriched for MS risk SNPs
with MS risk SNPs located in two VSE2 regions and two VSE3
regions (Figure 4A and Figures S3A–C). Interestingly, the genes
near the VSEs (i.e., UBASH3B, IRF8, PLEC, PARP10, GRINA) all
show stable high expression levels with onlymodest regulation by
stimulation (Table 4 and Figures S3B,C). For genes with a stable
and high expression level, even modest changes in expression
may lead to biological effects, such as the modest regulation of
MYC and ZMIZ1 by VDR (15, 47). Therefore, MS risk SNPs in
VSE regions may affect the function of VSEs that maintain the
high and stable expression of key genes rather than inducing
significantly higher expression.
Furthermore, almost all the risk SNPs located in SE regions
(40 of 45 SNPs in VSE, 70 of 85 SNPs in PSE, 33 of 33
SNPs in FSE) have RegulomeDB scores providing at least some
evidence for a functional role such as being an eQTL, having
transcription factor (TF) binding, a matched TF motif or DNase
I hypersensitivity. We list the SNPs with the top RegulomeDB
score for each SE gene in Table 4. Interestingly, among VSE1–3,
only VSE3 is enriched for MS risk SNPs (Figure 4A), which is
consistent with its higher GC content and high expression level.
The MS Risk ZMIZ1 Gene Set With VDR
Super-Enhancers
Booth and colleagues used cohorts to find MS risk genes that
are expressed differently in whole blood between MS patients
and healthy controls, and they found that ZMIZ1 and EOMES
are the most significant two, and that this result can be repeated
in other cohorts (13, 15). The ZMIZ1 gene is highly expressed
in myeloid cells including THP-1 monocytes and is considered
a risk gene for MS. The ZMIZ1 gene set (defined as genes
whose expression is positively correlated with that of ZMIZ1; see
methods) is under-expressed in the blood of MS patients and
has been proposed as a gene signature for MS (15). Importantly,
ZMIZ1 is also Vitamin D-responsive. Therefore, we tested
the association between VSEs and ZMIZ1 gene set in THP-1
cells. The ZMIZ1 gene set was downloaded from the file of a
publication by Fewings et al. (14, 15), consisting of the top 200
genes positively correlated with ZMIZ1 expression from each of
three cohorts (Supplementary File 1).
By GSEA enrichment analysis, a cluster of genes with VSE2
regions (ZMIZ1 gene cluster 1) from the ZMIZ1 gene set were
found to be enriched in genes that show a substantial change after
1,25(OH)2D3 stimulation (“High” region by log2(fold change)
in ZMIZ1 gene set, Figure 4B). Under the same experimental
conditions, a cluster of genes with VSE3 regions (ZMIZ1 gene
cluster 2) from the ZMIZ1 gene set is enriched in genes
that show a high expression level (“High” region by average
log2(expression) in ZMIZ1 gene set, Figure 4C).
Furthermore, ZMIZ1 itself also contains a VSE2 and is near a
VSE3 region (Figure 4D). Although the VSE2 and VSE3 around
ZMIZ1 do not overlap withMS risk SNPs, they may be connected
with SNPs via loops shown by CTCFChIA-PET data in K562 cells
from the ENCODE database (Figure 4D). In addition, among
the ZMIZ1 gene set, TOP1 has a VSE2 and is under significant
regulation by 1,25(OH)2D3. It is near (298.8 kb from) a MS
risk SNP rs6065333 (Figure S4A). GRB2 and DOCK2 have VSE3
regions and high expression levels. They are overlapped with
and near (440 kb from) MS risk SNPs rs9900529 and rs11957313,
respectively (Figures S4B,C).
We also used GO biological process and KEGG pathway
enrichment analysis to find potentially biologically important
genes in the two clusters of genes that are associated with
both VSE regions and MS risk. For ZMIZ1 gene cluster 1, we
found the genes ARHGEF2 and CLASP1 were enriched in five
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FIGURE 4 | The association of MS risk SNPs and ZMIZ1 gene set with VSE. (A) MS risk SNP enrichment in different SE regions. (B) VSE2-regulated genes are
enriched in ZMIZ1 positively associated genes with higher log2(fold change) (above); The names of these enriched VSE2-regulated genes (below). (C) VSE3-regulated
genes are enriched in ZMIZ1 positively associated genes with higher average log2(expression) (above); The names of these enriched VSE3-regulated genes (below).
(D) Visualization of signal densities and VSE region around ZMIZ1 gene.
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TABLE 4 | The gene near SE regions that overlap with MS risk SNPs.
SE region Gene in THP-1 cells after 1,25(OH)2D3 stimulation MS risk SNPs including SNPs in LD region
Gene Log2FC AveExpr Coordinate (0-based) dbSNP ID RegulomeDB score
VSE VSE2 UBASH3B −0.1253362 5.050095 chr11:122518524 rs6589939 3a
IRF8 −0.1469718 9.341672 chr16:86005837 rs68143182 5
VSE3 PLEC −0.5071387 8.468479 chr8:145007946 rs6989119 2a
PARP10 −0.2369997 7.492962 chr8:145013892 rs4073081 2a
GRINA 0.108769 7.872264 chr8:145014731 rs112979447 2a
PSE SYK 0.5603835 8.668792 chr9:93563535 rs290986 5
UBASH3B −0.1253362 5.050095 chr11:122527119 rs7129071 2a
FSE PLEC −0.5071387 8.468479 chr8:145007946 rs6989119 2a
PARP10 −0.2369997 7.492962 chr8:145013892 rs4073081 2a
GRINA 0.108769 7.872264 chr8:145014731 rs112979447 2a
DENND3 −0.1418788 7.662943 chr8:142104943 rs4961252 5
of the top six biological process terms. These enriched genes
relate mainly to the functions of microtubule, spindle, and actin
filament (Figure 5A). Among these biological process terms, the
enrichment of “leukocyte aggregation” for genes SEMA4D and
RAC2 had the most significant p-value (p = 3.45 × 10−5).
After KEGG pathway analysis, we found SEMA4D, RAC2 and
SSH1 are also significantly (p = 4.13 × 10−4) enriched in “axon
guidance” pathway (Figure 5B). These genes and their enriched
terms/pathways are potentially under the regulation of Vitamin
D via VSE2 regions and their impact on MS pathology has not
yet been tested.
For ZMIZ1 gene cluster 2, we found that the PRKCD and
GRB2 genes were included in all of the top six enriched
biological process terms, which related mainly to the functions
of actin filament, peptidyl-tyrosine, cellular component size and
phagocytosis (Figure 5C). The enrichment of “phagocytosis” for
genes PRKCD,GRB2, CD93, andDOCK2 has the most significant
p-value (p = 1.79 × 10−5). After KEGG pathway analysis,
the enrichment of PRKCD, GRB2, and DOCK2 in “chemokine
signaling pathway” showed the most significance (p = 3.01 ×
10−4) (Figure 5D). As mentioned above, the genes GRB2 and
DOCK2 are also within the ± 500 kb region of MS risk SNPs
(Figures S4B,C), and VSE regions around IL6R, PRKCD and
GRB2 are also enriched in the GO term: “positive regulation of
immune system process” (Figure 1D and Supplementary File 1).
These genes with a relative high expression level and their
enriched terms/pathways are potentially under the regulation
of Vitamin D via VSE3 regions and could be involved in the
etiology of MS.
DISCUSSION
Much research has occurred around classic SE regions, but
alterations of signal-induced SEs before and after stimulation
have not beenwell explored. In addition, the relationship between
many complex disease risk variants and environmental signal
SEs have not been explored, including the interaction between
Vitamin D induced VDR super-enhancers and MS risk SNPs in
the etiology of MS. In this study, we used publicly available data
(Table 1 and Table S1) to explore the features of VSE patterns
and their regulatory effects on gene expression using in silico
methods, in order to interrogate the role of the environmental
factor Vitamin D on MS. Additional in vitro or in vivo evidence
will be required to confirm the links between VSEs and MS risk
proposed here.
We particularly focused on the role of 1,25(OH)2D3-induced
SEs describing the distinct regions of VSEs compared with those
of PSEs and FSEs (Figure 1), and then classified VSEs into
three patterns: VSE1–3 (Figures 2A,B). VSE1–3 have different
characteristics including their association with the densities
of PU.1 binding and FAIRE-seq, the gene sets they regulate,
GC content, and gene expression level (Figures 2C, 3A,C–E).
We identified the genes with VSE1–3 regions that are also
under significant regulation of 1,25(OH)2D3 (Figures 3A,B
and Figure S1). We also showed that MS risk SNPs are
enriched in VSE regions, especially the VSE3 pattern of VDR
binding (Figure 4A and Figure S3A). This suggests that the
potential causal genes in the regions defined by SNP association
could be the ones that have VSE regions (Tables 3, 4 and
Figures S2, S3B,C). Moreover, we found that two clusters
of genes with VSE2 or VSE3 patterns are enriched in the
significantly regulated genes or highly expressed genes of the
ZMIZ1 gene set (Figures 4B,C and Figure S4). The genes we
identified in this study may be key points in the interaction
between the environmental factor Vitamin D and genetic risk
variants for the etiology and process of MS, and need further
exploration with specific experiments designed to assess the role
of the genetic variation in modulating Vitamin D regulated
gene expression.
FAIRE-seq, PU.1 ChIP-seq and VDR ChIP-seq have all been
used to capture enhancer regions in different cell types (48–50).
However, their super-enhancer regions in one cell type have not
been explored before. Our results showing distinct regions of
VSE, PSE, and FSE, is consistent with one previous study showing
that ERα, FoxA1 and AP2γ form different SE regions in MCF-7
cells (8). However, in another study (BioRxiv: http://dx.doi.org/
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FIGURE 5 | The biological process and signal pathway enrichment of ZMIZ1-associated gene clusters. (A) The GO BP terms enrichment for ZMIZ1 gene cluster 1.
(B) The KEGG signal pathway enrichment for ZMIZ1 gene cluster 1. (C) The GO BP terms enrichment for ZMIZ1 gene cluster 2. (D) The KEGG signal pathway
enrichment for ZMIZ1 gene cluster 2. Size of circle reflects the relative significance of p-value in each figure.
10.1101/105262), the SEs formed by TGF-β signal terminal TF
SMAD3 overlap a high proportion of the SEs formed by MED1
in mESC (73%) or in pro-B cells (64%). The research suggests
that classic (MED1) SEs can provide a platform for signaling
terminal TFs (SMAD3) to bind with a SE dense assembly,
although there are still a large proportion (∼60%) of SMAD3
SEs outside MED1 SE regions. Therefore, we hypothesize that
the signal SE and classic SE regions do not overlap by a large
proportion and are responsible for regulating different functional
genes as reported here for VDR and PU.1 in THP-1 monocytes.
However, if an external signal is important for cell differentiation
and identity, its terminal TF signal SE will overlap the majority
of classic SEs, in order to affect the expression of cell identity
genes in response to the signal, as seen with SMAD3 and MED1
in mESCs.
A previous studying investigating ERα SEs (8) indicated
that persistent ERα binding that existed both before and after
estrogen stimulation, initiated the generation of ERα SE regions
after stimulation. However, not all persistent signal TF ERα
bindings induce secondary ERα binding sites around them to
form SE regions after stimulation, and there are still some
secondary ERα binding sites that form SE regions independent
of persistent TF binding. Furthermore, there have been some
studies showing that primary (or transient), persistent, and
secondary signal TF binding have different characteristics. For
example, persistent signal TF binding sites have more canonical
motif enrichment (8, 16). In addition, by machine learning
approaches one study found that different combinations of
transient and persistent VDR binding sites in topologically
associating domains (TAD) regulate different biological processes
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(16). As one TAD may include multiple SE regions with
different generation mechanisms, here we focused on the SE
regions [potential sub-TAD regions (51)] and only analyzed their
combination of persistent and secondary signal TF binding.
We classified VSEs into three patterns based on the pattern of
persistent or secondary VDR binding following stimulation with
1,25(OH)2D3. While VSE2 and VSE3 patterns are correlated with
the signal density of PU.1 and FAIRE-seq peaks, VSE1 regions are
not. All three VSE patterns have significantly higher regulatory
effect on gene expression compared with VDR promoters and
VDR typical enhancers, but VSE3 has the highest level of gene
expression compared with other VDR binding regions.
Interestingly, we find that the ratio between the number
of VSE1–3 regions is signal-specific, i.e., different signals (e.g.,
Vitamin D, estrogen, or glucocorticoid) have different ratios
between the numbers of their signal SE1–3 (Table 2), potentially
corresponding to the different genomic functions (e.g., pioneer
TF, master TF, or just signal TF) of their terminal TFs (e.g.,
VDR, ERα, GR). The persistent VDR binding regions are ligand-
insensitive, and exist before signal stimulation. The effects of
VSE1 and VSE2 on gene expression after signal stimulation
reflect a transcriptional memory, which is similar to the control
of ligand-insensitive nuclear receptor PPARγ on the processive
macrophage polarization (52).
By connecting gene expression levels with VSE regions and
MS risk SNPs, we identified five significant VSE-regulated MS
risk genes: DENND6B, USP2, ASAP2, SEMA6B, and LRG1.
Among them, DENND6B is highly expressed in the brain
(53), and its protein interacts directly with Rab GTPases
involved in vesicle trafficking and cytokine production during
the process of neuroinflammation (54, 55). USP2, a de-
ubiquitinating enzyme, can regulate lipoprotein clearance by
promoting deubiquitinylation and preventing the degradation of
low-density lipoprotein receptor in HEK293T cells (56). In HL-
60 macrophages, USP2 can regulate LPS-induced production of
pro-inflammatory cytokines by reducing the polyubiquitination
of octamer-binding transcription factor (Oct)-1 (57). ASAP2 can
modulate Fc gamma receptor-mediated phagocytosis and cell
migration, which are potentially associated with efferocytosis-
mediated inflammation resolution and monocyte migration via
the blood-brain barrier (58, 59). SEMA6B is associated with
the signal pathway of “axon guidance” that is involved in both
peripheral and central nervous system development, the disorder
of which potentially impacts the pathology of MS. In particular,
some semaphorins, as immunemodulators, such as SEMA4D, are
involved in the immune response by regulating immune cell–cell
contacts and cell migration (60). In this study, we show that these
MS risk genes are all highly expressed and significantly regulated
by 1,25(OH)2D3 in THP-1 monocytes.
We also identified another five important MS risk genes
with VSEs overlapping with MS risk SNPs: UBASH3B, IRF8,
PLEC, PARP10, and GRINA. These genes are only modestly
regulated by 1,25(OH)2D3. However, modest regulation cannot
rule out their importance, especially when the genes have a
key biological function. Among them, UBASH3B has a protein
tyrosine phosphatase activity, which involves in the down-
regulation and degradation of receptor-type tyrosine kinases, and
promotes the accumulation of T cell receptors (61–63). The MS
risk gene IRF8 codes for an important transcription factor that
is associated with chronic inflammation and binds the upstream
regulatory region of type I IFN and IFN-inducible MHC class
I genes (64). MS risk SNP rs35929052 that is associated with
conversion to MS and disease relapse is close to IRF8 (65).
The expression of PLEC is changed by approximately 1.5-
fold after 1,25(OH)2D3 stimulation in THP-1 monocytes. The
related pathway of PLEC is “cytoskeletal signaling,” which is also
associated with cell migration and phagocytosis (www.genecards.
org) (66).
Finally, for analyzing the potential function of ZMIZ1-
associated genes, GO ontology and KEGG pathway analysis
were used. ARHGEF2, RAC2, SEMA4D, PRKCD, GRB2, and
DOCK2 were repeatedly enriched in important GO BP terms
or KEGG pathways, such as “axon guidance,” “phagocytosis,”
and “chemokine signaling,” which are all associated with the
pathology of MS and MS process. Importantly, these genes are
all Vitamin D-regulated and MS-associated.
Since VSE2 regions are formed based on pre-existing VDR
binding sites, the cell functions enriched for ZMIZ1 gene cluster
1, such as “leukocyte aggregation,” “actin filament organization,”
and “axon guidance,” are potentially predetermined to be
regulated by 1,25(OH)2D3 through forming VSE2 regions after
stimulation. Therefore, VSE2 formation will increase the basal
low-level expression of ZMIZ1 gene cluster 1 and promote its
associated functions after 1,25(OH)2D3 stimulation.
Because VSE3s are more active regulatory regions with the
highest GC content, and the genes with VSE3 regions have the
highest expression levels, it is not surprising that ZMIZ1 cluster
2 genes with VSE3 regions are enriched in highly expressed
genes. The cell functions enriched for ZMIZ1 gene cluster 2,
such as “phagocytosis” and “chemokine signaling,” are potentially
constitutively active in THP-1 monocytes. VSE3 formation will
sustain the basal high-level expression of ZMIZ1 gene cluster 2
and reinforce its functions after 1,25(OH)2D3 stimulation.
In summary, our results support the importance of signal-
induced nuclear receptor SEs in the signal stimulation process,
and detail the characteristics of signal SEs by classifying
1,25(OH)2D3-induced vitamin D receptor SE regions into three
patterns. Importantly, we connect MS risk SNPs with Vitamin D
downstream VSE regions for the first time.
In future research, the actions of signal SEs should be
an important consideration parallel to classic SEs, which
could provide more information about cell status with
signal perturbations and deeper insight into the regulatory
mechanisms of signal dependent transcription factors
(e.g., nuclear receptor, STATs, Smad3) in the genome. The
understanding of signal SEs can help elucidate the interaction
between environmental risk factors and genetic factors in the
onset and progression of complex diseases by allowing us to
explore the interaction between environmental signals and the
function/identity of causal cell-types. Important VSE-associated
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MS risk genes in monocytes were predicted, whose normal
functions may be disturbed by MS risk alleles around the
VSE regions. These genes that are associated with both VSE
and MS risk regions warrant further analysis to elucidate the
mechanisms involved.
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Figure S1 | The genes that are significantly regulated by VSE1–3. The genes that
are significantly regulated in the genome-wide MDplot from RNA-seq data. Blue
words: long non-coding RNA (Left). The genes that are significantly regulated in
the VSE finding curve (Right).
Figure S2 | The representative genomic regions of the genes with VSEs that are
associated with MS risk SNPs (bold in Table 3). (A) DENND6B. (B) USP2. (C)
ASAP2. (D) LRG1 and SEMA6B.
Figure S3 | The association between MS risk SNP and VSE1-3 region. (A) MS
risk SNPs enrichment in different SE regions. The permutation figure showed the
α = 0.05 expected values (red line) from 1,000 permutations and observed values
(green line). (B) The genomic regions of the genes with VSEs that are overlapped
with MS risk SNPs. (C) The genomic regions of the genes with PSE or FSE that
are overlapped with MS risk SNPs. VSE, VDR SE; PSE, PU.1 SE;
FSE, FAIRE SE.
Figure S4 | The representative genomic regions of the ZMIZ1-associated genes
with VSEs that are near MS risk SNPs. (A) TOP1. (B) GRB2. (C) DOCK2.
Table S1 | Control and hormone-stimulated ChIP-seq data.
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